PeerView Family Medicine & General Practice CME/CNE/CPE Audio Podcast

By PVI, PeerView Institute for Medical Education

PeerView (PVI) is a leading provider of high-quality, innovative continuing education (CME/CE/CPE and MOC) for clinicians and their interprofessional teams. Combining evidence-based medicine and instructional expertise, PeerView activities improve the knowledge, skills, and strategies that support clinical performance and patient outcomes. PeerView makes its educational programming and expert-led presentations and symposia available through its network of popular podcast channels to support specific specialties and conditions. Each episode includes a link to request CME/CE credit for participation. PeerView is solely responsible for the selection of topics, the preparation of editorial content, and the distribution of all materials it publishes.

  1. 1.
    Elizabeth A. Thiele, MD, PhD - Applying Evidence to Practice: Updated Consensus Recommendations for the Diagnosis, Surveillance, and Management of Tuberous Sclerosis Complex
  2. 2.
    Daniel J. Lovell, MD, MPH - Addressing the Burden of Polyarticular Juvenile Idiopathic Arthritis: A Roadmap to Improving Early Diagnosis and Treatment to Maximize Long-Term Outcomes
  3. 3.
    Benjamin W. Friedman, MD, MS, FAAEM, FACEP, FAHS - A New Era of Migraine Management: Recent Updates on Recognition, Acute Treatment, and Prevention for Emergency Physicians
  4. 4.
    Crystal M. Proud, MD - Data-Based Updates: Practical Application of Recent Evidence on Disease-Modifying Therapies for SMA
  5. 5.
    Karl E. Anderson, MD - Acute Hepatic Porphyria: Disease Diagnosis and Revelations Regarding the Role of siRNA Therapy
  6. 6.
    Brett King, MD, PhD - Addressing the Unmet Needs of Patients With Moderate to Severe Alopecia Areata: A Visual Exploration of Disease Pathogenesis and the Clinical Potential of Novel Therapeutic Options
  7. 7.
    April W. Armstrong, MD, MPH - Targeting the Burden of Moderate to Severe Psoriasis: A Visual Exploration of the Role of IL-17 Inhibitors in Improving Patient Care and Quality of Life
  8. 8.
    Jay B. Wish, MD - Targeting Hypoxia-Inducible Factor Stabilization as a Treatment for Anemia in Chronic Kidney Disease: Examining the Current State of the Science
  1. 9.
    Jay H. Shubrook, DO, FAAFP, FACOFP - Partnering With Peers and Patients: Achieving T2DM Treatment Goals With GLP-1 RA Therapy
  2. 10.
    Alexander (Ander) Cohen, MB BS (Hons), MSc, MD, FRACP, FESC - New Insights: How Does Real-World Evidence Influence VTE Management? A Visual Exploration of Real-World Studies of DOACs
  3. 11.
    Marwan Sabbagh, MD, FAAN, CCRI - Expert Perspectives on the Early Diagnosis of Alzheimer’s Disease and the Promise of Novel Therapies on the Horizon
  4. 12.
    Kristina M. Deligiannidis, MD - Test Your Knowledge: The Evidence for GABA-Modulating Neuroactive Steroids as a New Class of Rapid-Acting Antidepressants
  5. 13.
    John J. Russell, MD - Rewriting the Rules for Early Cancer Screening: Case-Based Insight on Primary Care Principles for Using Blood-Based Screening Techniques
  6. 14.
    Minetta C. Liu, MD - Innovative Blood-Based Screening in Cancer Care: State of the Science and Future Opportunities for Accelerating Cancer Diagnoses
  7. 15.
    Khaldoun G. Tarakji, MD, MPH - Adopting Telemedicine and Digital Tools for Nonvalvular Atrial Fibrillation Management and Stroke Prevention
  8. 16.
    Professor Thomas Powles, MBBS, MRCP, MD - Examining the State of the Science on New Therapies in Bladder Cancer: Perspectives on the Latest Developments Across the Disease Continuum
  9. 17.
    Philip J. Mease, MD, MACR - IL-17 Inhibitors in Nonradiographic Axial Spondyloarthritis: Expert Insight on Clinical Decision-Making in an Expanding Therapeutic Landscape
  10. 18.
    Ruben A. Mesa, MD, FACP / Jeanne M. Palmer, MD - How to Manage JAK Inhibition in Patients Undergoing HCT: Applying the Latest Clinical Evidence to Improve Patient Outcomes in Myelofibrosis
  11. 19.
    Jason J. Luke, MD, FACP - Expanding the Benefits of Immuno-Oncology to More Patients With Solid Tumors Through Novel Rational Targets and Combinations
  12. 20.
    Rishi P. Singh, MD - Taking an Individualized Approach to Neovascular Age-Related Macular Degeneration: Examining the Evidence to Improve Patient Outcomes
  13. 21.
    Jennifer I. Lim, MD, FARVO - A Quick Look at Recent Evidence for Improving Outcomes in Patients With Diabetic Retinopathy Using Anti-VEGF Therapy
  14. 22.
    Reynold A. Panettieri, Jr., MD - Improving Adherence to Evidence-Based Guidelines for the Diagnosis and Management of COPD: Practical Strategies for the Healthcare Team to Optimize Patient Care
  15. 23.
    Anne H. Cross, MD, FAAN / Prof. Xavier Montalban - Exploring the Rationale, Results, and Real-World Clinical Potential of BTK Inhibitors in the Management of Multiple Sclerosis
  16. 24.
    Professor Kausik Ray - Mastering the Management of Hyperlipidemia in Statin-Treated or Statin-Intolerant Patients: Recent Treatment Advances for Patients That Remain at High Risk of ASCVD
  17. 25.
    Mark Crowther, MD, MSc, FRCPC, FRSC - Managing Bleeding Events in Patients Receiving Direct Oral Anticoagulants: When Is It Appropriate to Implement Reversal Strategies in Patients With GI Bleeding?
  18. 26.
    Maria K. Houtchens, MD, MMs - MS Treatment Decisions Before, During, and After Pregnancy: Focus on the Use of Disease-Modifying Therapies
  19. 27.
    Bruce Cree, MD, PhD, MAS - Provider Perspectives on Current and Emerging Disease-Modifying Treatments for Multiple Sclerosis
  20. 28.
    Sagar Lonial, MD, FACP / Praneetha Thulasi, MD - Targeting Ocular Toxicity in Multiple Myeloma: Opportunities for Ophthalmology-Oncology Collaboration
  21. 29.
    George L. Bakris, MD - Improving Outcomes and Preventing Chronic Kidney Disease Progression: Evaluating the Role of Novel Nonsteroidal Mineralocorticoid Receptor Antagonists
  22. 30.
    Steven Fishbane, MD / Wendy L. St. Peter, Pharm.D, FCCP, FNKF, FASN - HIF-PH Inhibitors for Anemia in Chronic Kidney Disease: What Are Their Implications in Health-System Pharmacy?
  23. 31.
    Bruce R. Korf, MD, PhD - Targeting the RAS/MAPK Pathway in Neurofibromatosis Type 1 and Plexiform Neurofibromas: Improving Patient Outcomes With an Innovative Therapeutic Approach
  24. 32.
    Javed Butler, MD, MPH, MBA - Making the Case for Treating Iron Deficiency in Patients With Heart Failure
  25. 33.
    Sean Pokorney, MD, MBA - Improving Recognition of Nonvalvular Atrial Fibrillation to Reduce the Risk of Preventable Stroke: A Visual Guide for Clinicians
  26. 34.
    Orrin Devinsky, MD - Cannabidiol in the Treatment Arsenal for Severe Epilepsy Syndromes: Practical Guidance for Managed Care Professionals
  27. 35.
    "Eric Gapud, MD, PhD / Michael E. Wechsler, MD - Improving Recognition and Management of EGPA: A Multidisciplinary Approach to Individualizing Treatment"
  28. 36.
    Prof. Xavier Montalban - What’s New in Relapsing MS? Expert Perspectives on Pathogenesis, Targeting B Cells for Treatment, and Advances in Disease-State Monitoring
  29. 37.
    Kathleen N. Moore, MD, MS / Kristi Jhangiani, PharmD, BCPS - Managed Care Implications of the Expanding Role of PARP Inhibitors in Oncology: Evolving Evidence Base, Current Value Assessment Frameworks, and Considerations for Decision-Making in Managed Care Settings
  30. 38.
    Steven Fishbane, MD - Management of Hyperkalemia in Patients With Hemodialysis-Dependent Chronic Kidney Disease: Applying New Evidence and Best Practices for Improved Patient Outcomes
  31. 39.
    Amit Bar-Or, MD, FRCPC / Bruce Cree, MD, PhD, MAS - Realizing the Full Clinical Potential of Sphingosine-1-Phosphate Receptor Modulation to Improve Outcomes in Patients With Multiple Sclerosi
  32. 40.
    Peter Goadsby, MD, PhD - Addressing Unmet Needs in the Acute Treatment of Migraine: Focus on the Role of the 5-HT1F Receptor
  33. 41.
    Jonathan A. Bernstein, MD - Chronic Spontaneous Urticaria From Diagnosis to Treatment: Unique Perspectives on Employing a Multidisciplinary and Patient-Centric Approach to Care
  34. 42.
    Kurt Schalper, MD, PhD - Navigating the Complexities of Biomarker Testing in the Expanding Field of Precision Immuno-Oncology: Latest Evidence, Current Challenges, and Practical Guidance for Pathologists
  35. 43.
    Jay B. Wish, MD / Daniel W. Coyne, MD / Chilnille L. Milbrooks, MSN, FNP-C - Evolving Management Approaches to Anemia in Chronic Kidney Disease: Implications for the Nephrology Nurse
  36. 44.
    Jesse Papenburg, MD, MSc, FRCPC - Reducing the Burden of Influenza on Children: An Exploration of Novel and Emerging Antiviral Therapy
  37. 45.
    Karen Elta Anderson, MD - Finding the Path to Improved Recognition and Management of Tardive Dyskinesia
  38. 46.
    Concetta (Connie) DiDomenico, RN, MSN, PNP-BC, CPHON / Michael J. Fisher, MD - Targeting the RAS/MAPK Pathway in Neurofibromatosis Type 1, Plexiform Neurofibromas, and Optic Pathway Gliomas: Improving Patient Outcomes With an Innovative Therapeutic Approach
  39. 47.
    George Plitas, MD - The Era of Immuno-Oncology in TNBC: Navigating Evidence in Early-Stage and Advanced Disease, Practicalities of Integration, and Implications for Breast Surgeons
  40. 48.
    Kenneth C. Kalunian, MD / Maureen A. McMahon, MD / Joan T. Merrill, MD - Candid Conversations in Lupus: Navigating Advances in Diagnosis and Treatment to Provide Optimal Care for Each Patient
  41. 49.
    Ken Fujioka, MD - Leveraging the Tools at Hand: Current Perspectives on Weight-Loss Pharmacotherapy for Obesity Management
  42. 50.
    Perry Shieh, MD, PhD, FAAN - Ensuring Optimal Management Throughout the Clinical Spectrum of Spinal Muscular Atrophy

Listen to PeerView Family Medicine & General Practice CME/CNE/CPE Audio Podcast now.

Listen to PeerView Family Medicine & General Practice CME/CNE/CPE Audio Podcast in full in the Spotify app